HAEVSLABT• 7 Days (Normalized)
HAE vs LABT (Haemonetics Corporation vs Lakewood-Amedex Biotherapeutics Inc.)
Showing Closing Date Range from Sep 25 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
HAE Performance $104.68
-0.59%
Haemonetics Corporation
Normalized Baseline0.00%
LABT Performance $0.93
-44.16%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
Alpha Spread Margin HAE LEADS
+43.57 pts
HAE outperforming by 43.57 percentage points
HAELABT
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
HAE LABT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(6 dates)
| Date | HAE Price | HAE Gain (%) | LABT Price | LABT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $104.68 | -0.59% | $0.93 | -44.16% | +43.57% |
| Oct 01, 2026 | $104.37 | -0.88% | $- | - | |
| Sep 30, 2026 | $105.30 | +0.00% | $- | - | |
| Sep 29, 2026 | $105.80 | +0.47% | $0.99 | -40.72% | +41.19% |
| Sep 28, 2026 | $105.79 | +0.47% | $1.15 | -31.14% | +31.61% |
| Sep 25, 2026 | $105.30 | +0.00% | $1.67 | +0.00% | +0.00% |